NextCell Pharma AB
NXTCL SE0009723125
ICB 2010 : Health Care / Health CareSweden 141 57
SE-AB Huddinge Hälsovägen 7
Registration Number 556965-8361
Founded 2014
Previous Name(s):
Cellaviva AB
Startplattan 865057 Aktiebolag
Annual Performance 1
2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
-56% | -12% | -63% | 10% | -2% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Transactions: 21 Insiders: 7
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Patrik Fagerholm CFO |
2.36 SEK |
15,000 Bought |
35,400 SEK |
18/12/2024 | 18/12/2024 |
Anders Essen-möller CB |
1.26 SEK |
260,000 Sold |
327,600 SEK |
26/04/2024 | 25/04/2024 |
Hans Peter Torsten Ekre DIR |
2.95 SEK |
32,001 Bought |
94,403 SEK |
05/12/2023 | 05/12/2023 |
Patrik Fagerholm CFO |
3.85 SEK |
5,000 Bought |
19,250 SEK |
24/08/2023 | 24/08/2023 |
Patrik Fagerholm CFO |
3.90 SEK |
7,900 Bought |
30,810 SEK |
24/08/2023 | 24/08/2023 |
Patrik Fagerholm CFO |
3.95 SEK |
2,500 Bought |
9,875 SEK |
24/08/2023 | 24/08/2023 |
Hans Peter Torsten Ekre DIR |
8.00 SEK |
7,612 Bought |
60,896 SEK |
11/11/2021 | 11/11/2021 |
Anders Essen-möller CB |
15.80 SEK |
60,000 Sold |
948,000 SEK |
03/02/2021 | 03/02/2021 |
Hans-peter Ekre DIR |
12.35 SEK |
12,000 Sold |
148,200 SEK |
12/08/2020 | 12/08/2020 |
Hans Peter Torsten Ekre DIR |
12.93 SEK |
4,022 Sold |
51,984 SEK |
01/07/2020 | 30/06/2020 |